Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 186,600 | 126,700 | 787,000 | 561,100 | 352,200 |
| Depreciation Amortization | 131,400 | 64,600 | 280,400 | 203,800 | 136,400 |
| Income taxes - deferred | -1,200 | 9,300 | -140,200 | -8,700 | -20,600 |
| Accounts receivable | -91,500 | 33,200 | 36,100 | -10,800 | -136,700 |
| Accounts payable and accrued liabilities | -46,400 | -31,900 | -6,200 | -48,000 | -31,900 |
| Other Working Capital | -612,400 | -316,200 | 123,900 | -212,200 | -308,700 |
| Other Operating Activity | 467,400 | -30,200 | -115,700 | 17,800 | 141,300 |
| Operating Cash Flow | $33,900 | $-144,500 | $965,300 | $503,000 | $132,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65,100 | -31,900 | -197,800 | -160,700 | -94,300 |
| Net Acquisitions | -1,900 | N/A | 942,000 | 160,800 | -6,200 |
| Investing Cash Flow | $-67,000 | $-31,900 | $744,200 | $100 | $-100,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 415,700 | 204,700 | -1,559,100 | -320,100 | -8,700 |
| Debt Issued | N/A | N/A | 1,000 | N/A | N/A |
| Debt Repayment | -200,000 | -100 | -4,700 | -4,600 | N/A |
| Common Stock Issued | 10,900 | 4,100 | 80,800 | 67,300 | 42,900 |
| Common Stock Repurchased | -141,400 | N/A | N/A | N/A | N/A |
| Dividend Paid | -129,000 | -64,800 | -248,600 | -183,900 | -119,300 |
| Other Financing Activity | 22,300 | 1,800 | 17,600 | 10,700 | 16,300 |
| Financing Cash Flow | $-21,500 | $145,700 | $-1,713,000 | $-430,600 | $-68,800 |
| Exchange Rate Effect | 11,600 | 6,400 | 24,500 | 30,100 | 5,400 |
| Beginning Cash Position | 203,700 | 203,700 | 182,700 | 182,700 | 182,700 |
| End Cash Position | 160,700 | 179,400 | 203,700 | 285,300 | 150,800 |
| Net Cash Flow | $-43,000 | $-24,300 | $21,000 | $102,600 | $-31,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,900 | -144,500 | 965,300 | 503,000 | 132,000 |
| Capital Expenditure | -71,900 | -33,400 | -267,100 | -160,700 | -98,900 |
| Free Cash Flow | -38,000 | -177,900 | 698,200 | 342,300 | 33,100 |